<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01024348</url>
  </required_header>
  <id_info>
    <org_study_id>gozal123456</org_study_id>
    <nct_id>NCT01024348</nct_id>
  </id_info>
  <brief_title>Safety and Effectiveness of Tramadex-OD After Knee Arthroscopy</brief_title>
  <official_title>Open-label Study of the Safety and Effectiveness of Short-term Therapy With Extended-release Tramadol (TRAMADEX-OD) in the Management of Pain After Knee Arthroscopy.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Shaare Zedek Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Shaare Zedek Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Extended-release tramadol is indicated for the management of moderate to severe pain in
      adults who require around-the-clock treatment. It provides an extended duration of action,
      more constant plasma concentrations, a reduced dosing frequency, and the potential for
      improved compliance and therapeutic outcomes.

      The present study was designed to evaluate the safety and effectiveness of this medication in
      the treatment of early postoperative pain after knee arthroscopy.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>December 2009</start_date>
  <completion_date type="Anticipated">December 2011</completion_date>
  <primary_completion_date type="Anticipated">December 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Safety and effectiveness of TRAMADEX-OD will be evaluated by recording adverse events and using a visual analogue score for pain evaluation</measure>
    <time_frame>up to 48 hours</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Patient satisfaction will be evaluated by a telephone interview</measure>
    <time_frame>up to 48 hours</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Postoperative Pain</condition>
  <arm_group>
    <arm_group_label>Tramadex-OD</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients will undergo knee arthroscopy under spinal anesthesia without any opioid. 30 minutes prior to surgery and 24 hours afterwards, patients will take a tablet of 100 mg Tramadex-OD. Breakthrough pain will be managed with 1 gr paracetamol (per os) as needed.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients will undergo knee arthroscopy under spinal anesthesia without any opioid.Postoperative pain will be managed throughout the study with 1 gr paracetamol (per os) every 6 hours as required.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>extended-release tramadol</intervention_name>
    <description>30 minutes prior vto surgery and 24 hours afterwards, patients will take a tablet of 100 mg TRAMADEX-OD</description>
    <arm_group_label>Tramadex-OD</arm_group_label>
    <other_name>Tramadol</other_name>
    <other_name>Tramal</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>paracetamol</intervention_name>
    <description>in the control group, postoperative pain will managed with 1 gr paracetamol (per os) as needed (up to 4 times a day)</description>
    <arm_group_label>Control group</arm_group_label>
    <other_name>Acamol</other_name>
    <other_name>Acetominophen</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Men and nonpregnant women

          -  Age: 18-65 years

          -  ASA classification I or II

          -  ambulatory knee arthroscopy under spinal anesthesia

        Exclusion Criteria:

          -  Pregnancy

          -  Intolerance to any opioid, tramadol or paracetamol

          -  spine surgery in the past

          -  renal or hepatic impairment

          -  cardiac or respiratory conditions that put the patient at risk for respiratory
             depression

          -  patients receiving: monoamine oxidase inhibitors, carbamazepine, quinidine, selective
             serotonin reuptake inhibitors or tricyclic antidepressants
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yaacov Gozal, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Shaare Zedek Medical center, Jerusalem, Israel</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Yaacov Gozal, MD</last_name>
    <phone>972-2-6555614</phone>
    <email>gozaly@szmc.org.il</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Anna Lev, MD</last_name>
    <phone>972-2-6555104</phone>
    <email>anamlev@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Shaare Zedek Medical Center</name>
      <address>
        <city>Jerusalem</city>
        <zip>91031</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Yaacov Gozal, MD</last_name>
      <phone>972-2-6555614</phone>
      <email>gozaly@szmc.org.il</email>
    </contact>
    <investigator>
      <last_name>Yaacov Gozal, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>February 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 13, 2009</study_first_submitted>
  <study_first_submitted_qc>December 1, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 2, 2009</study_first_posted>
  <last_update_submitted>February 1, 2010</last_update_submitted>
  <last_update_submitted_qc>February 1, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 2, 2010</last_update_posted>
  <responsible_party>
    <name_title>Yaacov Gozal, MD</name_title>
    <organization>Shaare Zedek Medical Center, Jerusalem, Israel</organization>
  </responsible_party>
  <keyword>Surgery, knee arthroscopy</keyword>
  <keyword>Pain, postoperative</keyword>
  <keyword>tramadol, extended release</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acetaminophen</mesh_term>
    <mesh_term>Tramadol</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

